Search for: "SANDOZ, INC." Results 161 - 180 of 679
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2017, 5:44 pm by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Briefing: Sandoz Inc. v. [read post]
12 Jan 2017, 7:01 am by John Elwood
Sandoz Inc., 15-1195), and cases involving trial before nonlawyer judges (Davis v. [read post]
30 Dec 2016, 2:58 pm
The case addresses whether the “permission to appeal may be granted more readily in patent cases”.EPO bows to EU Commission on patentability of products of essentially biological processesAndrew Sharples discusses the impact on European Patent Office practice regarding the European Commission Notice concerning the Directive 98/44/EC, in which was found that products (plants, animals and their parts) obtained by essentially biological processes are not patentable.Monday MiscellanyThis… [read post]
21 Nov 2016, 12:00 am
  The Court of Appeal reiterated the approach to construction of numerical features and ranges in patent claims as set out in paragraph 38 of Smith & Nephew plc v ConvaTec Technologies Inc [2015] EWCA Civ 607. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
5 Sep 2016, 6:46 pm by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
25 Jul 2016, 4:15 am by Chittam Thakore Ph.D.
Sandoz Inc., the Federal Circuit concluded that an aBLA filer’s participation in the patent dance is not mandatory under the BPCIA. 794 F.3d 1347 (Fed. [read post]
13 Jul 2016, 4:15 am by Amy E. Hayden, Ph.D.
Sandoz Inc., the Federal Circuit’s first decision regarding the Biologics Price Competition and Innovation Act (BPCIA). [read post]